[PLX] YoY Quarter Result on 31-Dec-2010 [#Q4]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
23-Feb-2011
Financial Year
2010
Quarter
31-Dec-2010 [#Q4]
Profit Trend
QoQ- -244.70%
YoY- 42.90%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Revenue 1,122 48 2,362 1,176 388 0 0 -
PBT -10,885 968 968 22,414 31,440 9,390 -2,080 31.73%
Tax 0 -1,741 -27,616 -20,470 -16,504 -15,838 -20,800 -
NP -10,885 -9,877 -8,913 -8,528 -14,936 -6,576 -5,131 13.34%
Tax Rate - 179.86% 2,852.89% 91.33% 52.49% 168.67% - -
Total Cost 12,007 9,925 11,275 9,704 15,324 6,576 5,131 15.20%
Ratio Analysis
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
NP Margin -970.14 -20,577.08 -377.35 -725.17 -3,849.48 0.00 0.00 -
Per Share
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
EPS -1.18 -1.07 -1.01 -1.04 -1.85 -0.87 -0.70 9.08%
EPS Diluted -1.17 -1.07 -1.01 -1.04 -1.85 -0.87 -0.68 9.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.